Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

neurology > neuromuscular disorders > Flashcards

neuromuscular disorders Flashcards

1
Q

what hormone is released within the NMJ

A

ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

examples of disorders at each of the following parts of the LMN pathway:
o Anterior horn cell
o Peripheral nerve
o NMJ
o Muscle

A

o Anterior horn cell eg. SMA
o Peripheral nerve eg. CMT
o NMJ eg. myasthenia
o Muscle eg. myopathies, muscular dystrophies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

myopathy vs dystrophy vs neuropathy

A

myopathy = FUNCTIONAL
disorder of the contractile apparatus
proximal
static dysfunction
can be a/w pain
tendon stretch reflex preserved
CK normal/elevated

dystrophy:
disorder of the supporting apparatus
proximal
dysfunction more progressive
no pain
tendon stretch reflex preserved
CK classically ++++

neuropathy:
DISTAL
tendon stretch reflex LOST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

characteristic feature of NMJ problems

A

fatiguability!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

floppy infant - two best discriminators

A

Floppy weak and ARREFLEXIC – neuromuscular: no or reduced antigravity movements
Floppy strong – central: can move against gravity (may have mild weakness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

phasic vs postural tone

A

phasic = appendicular tone i.e. tone in extremities
postural = axial tone (neck/trunk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

arreflexia vs hyporreflexia in LMN problems - points to where in the LMN?

A

arreflexia = anterior horn cell, neuropathy
hyporreflexia = NMJ, muscular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what must you never forget in floppy infant examination

A

EXAMINE MOTHER - ask them to squeeze your hands! subclinical presentation of myotonic dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do these gait examination findings suggest?
waddling gait
gower’s sign
ability to go up and down one foot per step
cannot heel toe walk/hop

A

waddling gait = proximal weakness
gower’s sign = proximal weakness
ability to go up and down one foot per step = proximal intact
cannot heel toe walk/hop = imbalance / distal weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

fasciculation means what?

A

denervation - classically anterior horn problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NCS: electro-decrement vs increment suggestive of what?

A

electro-decrement = NMJ like myasthenia
electro-increment = post-synaptic NMJ like botulism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NCS: reduced conduction vs amplitude means what?

A

conduction = myelin problem e.g. CMT
amplitude = less nerve fibres / less muscle fibres responding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EMG vs NCS

A

NCS = detects problem with nerve
EMG = stick probe in muscle and test whether its working properly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

main aetiologies to consider for myopathies

A
  1. congenital
  2. endocrine: TH, PTH, GH
  3. iatrogenic e.g. steroid
  4. metabolic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

most common manifestations of congenital myopathies

A
  1. floppy infant with bady resp
  2. later presentation with delayed milestones
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

main types of congenital myopathy we care about, their key exam features and which is most common.

A
  1. Nemaline myopathy (most common)
    - ACTA1 most common
    - neonatal most common, infantile presentation possible
    - muscle biopsy with nemaline rods is diagnostic
  2. Centronuclear/ myotubular myopathy
    - no facies!
    - bad neonatal common
  3. Congenital fiber type disproportion
    - neonates floppy no resp
  4. Central core disease
    - ryanodine (RYR1) mutations
    - typically walk for a few years
    - malignant hyperthermia, no volatile anaesthetics!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

thyrotoxicosis vs hypothyroid myopathy

A

both symmetric proximal weakness and muscle wasting ++
hypothyroid: hypotonia also, and necrosis on biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

pattern of myopathy in steroid-induced myopathy

A

painless, symmetrical, progressive proximal weakness
mostly reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

inheritance pattern of the following muscular dystrophies:
- myotonic dystrophy
- LGMD
- DMD/BMD
- congenital muscular dystrophies
- EDMD
- FSHD

A

i. AD – myotonic dystrophy, FSHD, LGMD type 1
ii. AR – congenital muscular dystrophies, LGMD type 2
iii. X-linked – DMD/BMD, EDMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

BMD vs DMD

A

DMD:
nonsense frameshift > no dystrophin
<5yo onset, wheelchair dependent <13yo
death ~21yo

BMD:
missense, normal reading frame > dysfunctional dystrophin
>5yo onset, wheelchair dependent >16yo
preservation of neck flexor muscles
DCM causing HF more common
death ~40s-50s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what does dystrophin do?

A

stabilises sarcolemma by connecting the actin cytoskeleton to the muscle membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

DMD inheritance pattern

A

70% X-linked
30% de novo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

DMD - explain mums with negative test who can still have kids with DMD

A

gonadal mosaicism - some eggs have it, some don’t, but blood tests won’t show

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

key complications of DMD

A

contractures
scoliosis
cardiomyopathy
ID, learning problems
resp failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
key features of DMD exam
gower's sign and trendelenberg pseudohypertrophy of calves weak neck flexors (cf BMD) lordosis **facial and extra-ocular muscle sparing** (cf other dystrophies e.g. FSHD)
26
what can help ambulation in dmd and bmd
glucocorticoids (not dexa): offer at time of decline and frequent falls 4-6yo prolongs ambulation by 2-3y, preserves resp/cardiac function a little
27
female heterozygotes for DMD - what to remember?
at risk of DCM - need to have cardiac evaluation
28
exercise and neuromuscular conditions - comment
Exercise not dangerous in any neuromuscular condition don't exercise past the point of pain
29
key features of limb girdle muscular dystrophy for exams - and what to not confuse it with
progressive pelvic weakness > down early adulthood onset pseudohypertrophy of calves but not common - don't confuse with BMD not all limb girdle weakness is LGMD - think SMA3 and 4
30
key features of FSMD for exams
AD late childhood onset face, shoulder blades, upper arms and ABDO weakness - can walk initially mask-like facies, beevor sign positive
31
key features of emery-dreifuss muscular dystrophy
X-linked, 5-15yo 1. early onset contractures 2. weakness in scapulo-humeral distribution 3. ***DCM****!!
32
myotonic dystrophy: DM1 vs DM2 genetics
DM1 = expansion of trinucleotide repeat CTG in DMPK gene - >35 repeats = worse, >50 = worst. DM2 = expansion of tetranucleotide repeat CCTG - no correlation between repeat length and severity
33
explain the concept of anticipation in DM1.
Pathogenic alleles (>35) unstable and may expand in length during gametogenesis > transmission of a longer trinucleotide repeat allele associated with earlier onset and more severe disease (esp if from mum)
34
DM1 vs DM2 clinical manifestation
DM1 = can occur from neonate > adult; more severe DM2 = adult onset; less severe
35
differentiate DM1 phenotypes
1. congenital (>1000 repeats) = worst 2. childhood onset (>800): <10y, involvement of other organs besides skeletal muscle 3. classical (most common): adolescence 4. mild adult (>50): cataracts + myotonia 5. premutation (<50 repeats) - no signs
36
clinical manifestations of myotonic dystrophy
1. cranial muscle problems e.g. face/speech/ptosis 2. CNS: mental retardation 3. eyes: cataracts 4. cardiac 5. resp 6. GI: megacolon, dysphagia, constipation/incontinence 7. endocrine: DM + hypogonadism 8. DISTAL to proximal weakness 3. myotonia
37
what is myotonia
Delayed relaxation of muscle after voluntary or involuntary contraction (e.g. percussion)
38
key features of congenital myotonic dystrophy
1. resp failure 2. profound hypotonia 3. poor feeding 4. arthrogryposis 5. facial diplegia with inverted v lips 6. polyhydramnios
39
congenital muscular dystrophy distinguishing feature from congenital myotonic dystrophy
congenital muscular dystrophy - high association with brain malformations e.g. lissencephaly
40
anaesthetics in neuromuscular disorders - key points
1. risk of cardio-resp failure 2. hypersensitivity to sedative agents 3. major AE: malignant hyperthermia, rhabdo, hyperkal
41
pathogenesis of myasthenia gravis
AI disease from anti-AChR antibodies blocking receptor activity at the post-synapse terminal
42
classic myasthenia gravis clinical manifestations
1. **rapid fatigue of muscles** 2. *weakness worse at end of day* 3. ptosis, ophthalmopegia, diplopia WITHOUT acuity issues 4. NO fasciculations, myalgias, sensory symptoms
43
natural history of childhood myasthenia gravis
50% ocular MG will be generalised in 2 years maximal disease severity in 2y spontaneous remission possible, more common in younger
44
what is a myasthenic crisis?
acute or subacute severe increase in weakness in patients with MG precipitated by stress/physical stress, which can be severe enough to require IV cholinesterase, IVIG, plasma exchange, vent support
45
key Ix for myasthenia gravis
1. Anti-AChR 2. Anti-MusK (usually young bulbar females, not pure ocular) 3. electro-decremental response in nerve conduction study ONLY in affected muscles, but velocity remains normal 4. administration of short acting cholinesterase inhibitor e.g. edrophonium / neostigmine - ptosis and ophthalmoplegia improve in a few seconds
46
management options for MG
1. 1st line anti-cholinesterase e.g. neostigmine 2. short term - exchange / IVIG 3. long term - roids / AZA 4. surgical - thymectomy
47
distinguish between acquired and congenital myasthenia
acquired not autoimmune at all, no anti-ACh-Ab permanent static disorder WITHOUT remission most do NOT experience myasthenic crisis
48
how does botulism work to cause paralysis?
botulism binds to peripheral cholinergic nerve endings, neurotoxin damages SNARE proteins > prevents fusion of vesicles with pre-synaptic membrane to release ACh
49
key features of lambert eaton syndrome and differences with myasthenia gravis
auto-abs to Ca channels at pre-synaptic neuron > no ach release a/w malignancy + paraneoplastic syndrome (SCC) improves temporarily after repeated use of muscle
50
name the 4 anterior horn diseases we care about
polio enterovirus (polio-like) ALS SMA
51
key features of SMA for exams
prox to distal weakness symmetrical - SNS and PNS affected areflexia / hyporeflexia hypotonia fasciculations from denervation resp insufficiency heart and IQ are fine
52
genetics of SMA
AR mutation of telomeric SMN1, leaving centromeric SMN2 to do the job - number of SMN2 copies left determines severity of SMA
53
differentiate the types of SMA
SMA 0: prenatal onset, death by 6mo SMA 1: infantile <6mo onset. never sit, feeding problems, death by 2yo SMA 2: late infantile 6-18mo onset, never walk can sit, can live to 20y SMA 3: >2y onset, walk ok. slower progression, can hypertrophy not atrophy. SMA 4: adult onset, pretty much normal.
54
diagnostic Ix of SMA
genetic SMN test
55
new therapy for SMA
nusinersan = antisense oligonucleotide binds SMN2 pre-mRNA to prevent exon 7 from being removed > making more SMN protein
56
what are the two exceptions to prox to distal weakness?
DISTAL to proximal weakness: SMARD (cf SMA1) myotonic dystrophy MD1
57
when is myelination of peripheral nerves complete
2-3yo
58
CMT also known as
hereditary motor sensory neuropathy (HMSN)
59
key points of CMT pathophys
- GROUP of disorders causing chronic motor AND sensory polyneuropathy - defective proteins in myelin sheath (CMT1A most common) OR axon (CMT2)
60
key features of CMT diseases
1. Length-dependent muscle wasting and weakness = distal > proximal + LL > UL 2. reduced DISTAL reflexes 3. impaired DISTAL sensation; vibration affected EARLIER than pin-prick 4. foot deformity – reflection of chronicity
61
CMT genetics - most common?
mostly from AD of CMT1A = duplication of PMP22
62
diagnostic study of CMT
Sural nerve biopsy: large and medium size myelinated fibres are reduced in formation, collagen is increased and characteristic onion bulb formations of proliferated Schwann cell cytoplasm surrounds axons
63
earliest and most severely affected nerves in CMT
peroneal and tibial nerves > walking runnning issues with ortho issues
64
which is better for CMT - nerve conduction or EMG
nerve conduction (both motor and sensory velocity slower)
65
key features of CMT1 vs CMT2 vs CMT3
CMT1: demyelination first-second decade CMT2: axonal damage second-third decade variable foot deformity CMT3 = Dejerine-Sottas Disease demyelination <2y foot deformity common
66
name three common exam drugs causing peripheral neuropathy
Vincristine, cisplatin and paclitaxel
67
infections vs vaccines particularly associated with guillan-barre
Infections i. GIT = campylobacter jejuni, H pylori ii. Respiratory = Myocoplasma pneumoniae Vaccines particularly associated with GBS i. Rabies ii. Influenza iii. Oral polio iv. Conjugated menincoccal C vaccine
68
key features of Guillan Barre for exams
- acute inflammatory polyneuropathy - rapidly progressive symmetric weakness - prox=dist, LL > UL - acutel no progression past 4 weeks - areflexia - CN involvement (facial, bulbar, ophthalmoplegia) - autonomic instability - sensory - pain/dyasthesia
69
key CSF findings in guillan-barre
WCC <10 cells/mm3 and protein >0.45 g/L (cytoalbuminologic dissociation)
70
what key investigations should be considered if suspecting guillan barre
1. csf ***cytoalbuminologic dissociation*** 2. nerve conduction studies: slow 3. MRI: *nerve root enhancement* 4. stool: for polio and campylobacter 5. bloods: - Anti-GM1: campylobacter associated GBS - Anti-GQ1b: Miller Fisher syndrome (and bc, etc)
71
Mx options in guillan barre
1. resp support 2. IVIG 2g/kg over 2 days if bad - help speed recovery not change outcome 3. neuropathic pain: gaba/nsaids/*steroids- don't change outcome
72
outcome for guillan-barre in kids
90% of children fully recover – small number have mild weakness Relapses uncommon d. Very small percentage later develop CIDP
73
chronic inflammatory demyelinating polyradiculopathy (CIDP) - key features for exam
like long-term guillan barre but CN/bulbar uncommon course is different - either relapsing/remitting or progressive
74
key features of miller-fisher syndrome
ophthalmoplegia, ataxia and areflexia do not have significant lower extremity weakness
75
first test for DMD and why
60% have deletion - so first do a microarray

neurology (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions